Posts by: Ines Martins, PhD

Ines Martins, PhD

Inês Martins holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.

September 2, 2016September 2, 2016

Erelzi, a Biosimilar to Enbrel, Approved by FDA for Rheumatoid Arthritis, Other Inflammatory Diseases

News

The U.S. Food and Drug Administration (FDA) has approved Novartis‘ Erelzi (etanercept-szzs) for a number of inflammatory diseases, including rheumatoid arthritis (RA). Erelzi, a TNF inhibitor, was approved as a biosimilar to ... Read more

August 29, 2016August 29, 2016

Predictors Identified for Severe Cervical Spine Instabilities in RA Patients

News

Patients with rheumatoid arthritis (RA) are more likely to exhibit cervical spine instabilities if they have a history of corticosteroid treatment or joint surgery and the presence of mutilating changes, ... Read more

August 24, 2016August 24, 2016

Rheumatoid Arthritis Patients on Kineret at High Risk of Strep Infections, Study Says

News

Rheumatoid arthritis patients using medications that are interleukin-1β (IL-1β) receptor antagonists, like Kineret (anakinra), may be at much higher risk of infections with Group A Streptococcal bacteria, a flesh-eating bacteria that is the cause ... Read more

August 15, 2016August 15, 2016

Chances for Heart Disease with Rheumatoid Arthritis May Decrease Via HDL Control

News

Rheumatoid arthritis (RA) treatments can reduce the risk for cardiovascular diseases (CVD) when restoration of normal HDL anti-oxidant functions is achieved, according to researchers at the University of California Los Angeles ... Read more

July 27, 2016July 27, 2016

Gut Bacteria Might Predict, Prevent Rheumatoid Arthritis Start, Severity

News

New studies suggest that bacteria in the gut may predict susceptibility to rheumatoid arthritis (RA), be used by physicians to prevent disease onset, and that altering the gut microbiome composition can improve RA ... Read more

June 29, 2016June 29, 2016

Women With Rheumatoid Arthritis Have Higher Cardiovascular, Respiratory Disease-Related Mortality

News

Women with rheumatoid arthritis (RA) have higher respiratory and cardiovascular disease-derived mortality than those without RA, according to a recent study. “Rheumatoid Arthritis and Mortality Among Women During 36 Years ... Read more

June 9, 2016June 9, 2016

Humira Has Dual Role in Suppressing Inflammation in Rheumatoid Arthritis Patients

News

A new study developed by researchers at the University College London in England has identified a new role for the anti-inflammatory drug Humira (adalimumab) in rheumatoid arthritis (RA): It works ... Read more

June 6, 2016June 7, 2016

Methotrexate-Refractory Rheumatoid Arthritis Patients See Better Results with Combo Drug Treatment, According to Analysis

News

Korean researchers compared the efficacy of a number of biological agents in rheumatoid arthritis (RA) patients refractory to methotrexate (MTX), and found that certolizumab and golimumab, two monoclonal antibodies that ... Read more

April 22, 2016April 22, 2016

Omega-3 Rich Diet Seen to Have ‘Potent’ Effects in Treating a Mouse Model of Rheumatoid Arthritis

News

Rheumatoid arthritis (RA) may be effectively treated with the lipid mediator resolvin D1, a metabolite of omega-3 fatty acids, according to a study that found a pronounced easing of the disease in ... Read more